This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Veracyte (VCYT) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Veracyte (VCYT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Zacks.com featured highlights include: Twitter, ServiceNow, Fortinet, Tactile Systems and Navigant Consulting
by Zacks Equity Research
Zacks.com featured highlights include: Twitter, ServiceNow, Fortinet, Tactile Systems and Navigant Consulting
5 Top Stocks Backed by Earnings Beat Potential
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next release.
Zacks.com featured highlights include: IAC/InterActiveCorp, Tactile Systems Technology, Martin Marietta Materials, Fortinet and Intuit
by Zacks Equity Research
Zacks.com featured highlights include: IAC/InterActiveCorp, Tactile Systems Technology, Martin Marietta Materials, Fortinet and Intuit
These 5 Top Stocks May Surprise You With an Earnings Beat
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next releases.
Tactile Systems Technology (TCMD) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 166.67% and 14.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Invest in DENTSPLY (XRAY) Stock Now
by Zacks Equity Research
Strong prospects in emerging markets provide DENTSPLY (XRAY) a competitive edge in the MedTech space.
AngioDynamics' (ANGO) Q3 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Despite strength in the VIT business, AngioDynamics (ANGO) exited third-quarter fiscal 2019 on a tepid note, with both earnings and revenues missing estimates.
Glaukos (GKOS) Banks on Solid Pipeline Amid Stiff Competition
by Zacks Equity Research
Glaukos' (GKOS) strong pipeline is indicative of brighter prospects ahead. However, cutthroat competition in the medical-device industry is worrisome.
AngioDynamics Gets FDA Nod to Begin NanoKnife DIRECT Study
by Zacks Equity Research
AngioDynamics' (ANGO) launches AngioDIRECT.com for enrolling participants as part of the DIRECT clinical study.
Zacks.com featured expert Kevin Matras highlights: Columbia Sportswear, Tactile Systems Technology, Wright Medical, Carbonite and Palo Alto Networks
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Columbia Sportswear, Tactile Systems Technology, Wright Medical, Carbonite and Palo Alto Networks
Play Potential Earnings Beat With These 5 Top Stocks
by Sanghamitra Saha
These top-ranked stocks are likely to beat on the bottom line in their next release.
Analysts Estimate Tactile Systems Technology (TCMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Tactile Systems Technology (TCMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Moving Average Crossover Alert: Tactile Systems Technology
by Zacks Equity Research
Tactile Systems Technology, Inc. (TCMD) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Tactile Systems Technology (TCMD) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 80.00% and 7.00%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Tactile Systems Technology (TCMD) Q3 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Tactile Systems Technology (TCMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tactile Systems Technology (TCMD) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of 16.67% and 9.57%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
5 Top Performing Stocks of the Best ETF of 1H2018
by Sweta Killa
Inside the top performing stocks of the top ETF of the first half of 2018.
RTI Surgical (RTIX) to Acquire Zyga, Improve Spine Surgeries
by Zacks Equity Research
RTI Surgical (RTIX) to integrate Zyga's SImmetry Sacroiliac Joint Fusion System to diversify Spine franchise.
FDA Nod for Zimmer Biomet's Sidus, Aids Arthroplasty Arm
by Zacks Equity Research
Zimmer Biomet's (ZBH) Sidus Stem-Free Shoulder system offers a minimal bone resection in total shoulder arthroplasty, which the company claims to help reduce pain and restore a range of motions.
Entellus (ENTL) Nears 52-Week High: What's Driving It?
by Zacks Equity Research
Entellus Medical Inc. (ENTL) gains from latest technology and promising revenue trends.
Is Tactile Systems Technology (TCMD) a Great Growth Stock?
by Zacks Equity Research
Tactile Systems Technology (TCMD) is seeing solid earnings estimate revision and has a favorable Zacks rank, making it well positioned for future earnings growth.
Cogentix (CGNT) Stock Near 52-Week High: More Room to Run?
by Zacks Equity Research
Cogentix Medical (CGNT) stock continues to hover around the 52-week high mark reached on Dec 27, courtesy of its new strategies.
Robust Pipeline Aids Edwards Lifesciences, Rising Costs Ail
by Zacks Equity Research
Edwards Lifesciences' (EW) pipeline building to fortify foothold across all operating businesses bodes well. Also, the TAVR adoption rate across Japan and the European countries is impressive.
Align Rides on Balanced Segmental Growth Amid Stiff Contest
by Zacks Equity Research
Align (ALGN) gains from balanced sales growth across all its channels of late, primarily on high InvisAlign Technology case volumes.